188 related articles for article (PubMed ID: 7042896)
1. Formation of Charcot-Leyden crystals by human basophils.
Ackerman SJ; Weil GJ; Gleich GJ
J Exp Med; 1982 Jun; 155(6):1597-609. PubMed ID: 7042896
[TBL] [Abstract][Full Text] [Related]
2. Localization of eosinophil granule major basic protein in human basophils.
Ackerman SJ; Kephart GM; Habermann TM; Greipp PR; Gleich GJ
J Exp Med; 1983 Sep; 158(3):946-61. PubMed ID: 6350526
[TBL] [Abstract][Full Text] [Related]
3. Ultrastructural localization of the Charcot-Leyden crystal protein (lysophospholipase) to granules and intragranular crystals in mature human basophils.
Dvorak AM; Ackerman SJ
Lab Invest; 1989 Apr; 60(4):557-67. PubMed ID: 2709814
[TBL] [Abstract][Full Text] [Related]
4. Charcot-Leyden crystal protein in the degranulation and recovery of activated basophils.
Golightly LM; Thomas LL; Dvorak AM; Ackerman SJ
J Leukoc Biol; 1992 Apr; 51(4):386-92. PubMed ID: 1373430
[TBL] [Abstract][Full Text] [Related]
5. The gene for human eosinophil Charcot-Leyden crystal protein directs expression of lysophospholipase activity and spontaneous crystallization in transiently transfected COS cells.
Zhou Z; Tenen DG; Dvorak AM; Ackerman SJ
J Leukoc Biol; 1992 Dec; 52(6):588-95. PubMed ID: 1464731
[TBL] [Abstract][Full Text] [Related]
6. Differences between basophils and mast cells: failure to detect Charcot-Leyden crystal protein (lysophospholipase) and eosinophil granule major basic protein in human mast cells.
Leiferman KM; Gleich GJ; Kephart GM; Haugen HS; Hisamatsu K; Proud D; Lichtenstein LM; Ackerman SJ
J Immunol; 1986 Feb; 136(3):852-5. PubMed ID: 3510254
[TBL] [Abstract][Full Text] [Related]
7. Human eosinophil lysophospholipase: the sole protein component of Charcot-Leyden crystals.
Weller PF; Bach D; Austen KF
J Immunol; 1982 Mar; 128(3):1346-9. PubMed ID: 6173432
[TBL] [Abstract][Full Text] [Related]
8. Ultrastructural localization of the Charcot-Leyden crystal protein (lysophospholipase) to a distinct crystalloid-free granule population in mature human eosinophils.
Dvorak AM; Letourneau L; Login GR; Weller PF; Ackerman SJ
Blood; 1988 Jul; 72(1):150-8. PubMed ID: 2455566
[TBL] [Abstract][Full Text] [Related]
9. Crystal structure of human Charcot-Leyden crystal protein, an eosinophil lysophospholipase, identifies it as a new member of the carbohydrate-binding family of galectins.
Leonidas DD; Elbert BL; Zhou Z; Leffler H; Ackerman SJ; Acharya KR
Structure; 1995 Dec; 3(12):1379-93. PubMed ID: 8747464
[TBL] [Abstract][Full Text] [Related]
10. Ultrastructural localization of Charcot-Leyden crystal protein in human eosinophils and basophils.
Calafat J; Janssen H; Knol EF; Weller PF; Egesten A
Eur J Haematol; 1997 Jan; 58(1):56-66. PubMed ID: 9020375
[TBL] [Abstract][Full Text] [Related]
11. Localization of Charcot-Leyden crystal protein in individual morphological phenotypes of human basophils stimulated by f-Met peptide.
Dvorak AM; MacGlashan DW; Warner JA; Letourneau L; Morgan ES; Lichtenstein LM; Ackerman SJ
Clin Exp Allergy; 1997 Apr; 27(4):452-74. PubMed ID: 9146940
[TBL] [Abstract][Full Text] [Related]
12. Heterogeneity of human peripheral blood eosinophil-type colonies: evidence for a common basophil-eosinophil progenitor.
Denburg JA; Telizyn S; Messner H; Lim B; Jamal N; Ackerman SJ; Gleich GJ; Bienenstock J
Blood; 1985 Aug; 66(2):312-8. PubMed ID: 2410064
[TBL] [Abstract][Full Text] [Related]
13. Mature eosinophils stimulated to develop in human cord blood mononuclear cell cultures supplemented with recombinant human interleukin-5. Part I. Piecemeal degranulation of specific granules and distribution of Charcot-Leyden crystal protein.
Dvorak AM; Furitsu T; Letourneau L; Ishizaka T; Ackerman SJ
Am J Pathol; 1991 Jan; 138(1):69-82. PubMed ID: 1987770
[TBL] [Abstract][Full Text] [Related]
14. Formation of Charcot-Leyden crystals by human basophils in sputum and peripheral blood.
Tanabe K; Takahashi K; Maeda M; Kimura I
Acta Med Okayama; 1993 Apr; 47(2):85-90. PubMed ID: 8506754
[TBL] [Abstract][Full Text] [Related]
15. Charcot-Leyden crystal protein distribution in basophils and its absence in mast cells that differentiate from human umbilical cord blood precursor cells cultured in murine fibroblast culture supernatants or in recombinant human c-kit ligand.
Dvorak AM; Ishizaka T; Letourneau L; Albee EA; Mitsui H; Ackerman SJ
J Histochem Cytochem; 1994 Feb; 42(2):251-63. PubMed ID: 7507143
[TBL] [Abstract][Full Text] [Related]
16. Molecular cloning and characterization of human eosinophil Charcot-Leyden crystal protein (lysophospholipase). Similarities to IgE binding proteins and the S-type animal lectin superfamily.
Ackerman SJ; Corrette SE; Rosenberg HF; Bennett JC; Mastrianni DM; Nicholson-Weller A; Weller PF; Chin DT; Tenen DG
J Immunol; 1993 Jan; 150(2):456-68. PubMed ID: 8419478
[TBL] [Abstract][Full Text] [Related]
17. Ultrastructural localization of Charcot-Leyden crystal protein (lysophospholipase) and peroxidase in macrophages, eosinophils, and extracellular matrix of the skin in the hypereosinophilic syndrome.
Dvorak AM; Weller PF; Monahan-Earley RA; Letourneau L; Ackerman SJ
Lab Invest; 1990 May; 62(5):590-607. PubMed ID: 2160562
[TBL] [Abstract][Full Text] [Related]
18. Human eosinophil Charcot-Leyden crystal protein: cloning and characterization of a lysophospholipase gene promoter.
Gomolin HI; Yamaguchi Y; Paulpillai AV; Dvorak LA; Ackerman SJ; Tenen DG
Blood; 1993 Sep; 82(6):1868-74. PubMed ID: 8400237
[TBL] [Abstract][Full Text] [Related]
19. Human cord blood derived immature basophils show dual characteristics, expressing both basophil and eosinophil associated proteins.
Grundström J; Reimer JM; Magnusson SE; Nilsson G; Wernersson S; Hellman L
PLoS One; 2012; 7(10):e48308. PubMed ID: 23118978
[TBL] [Abstract][Full Text] [Related]
20. Identification of human eosinophil lysophospholipase as the constituent of Charcot-Leyden crystals.
Weller PF; Goetzl EJ; Austen KF
Proc Natl Acad Sci U S A; 1980 Dec; 77(12):7440-3. PubMed ID: 6261258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
